The forecasted data indicates a steady increase in respiratory system disease mortality among males in the US from 2024 to 2028. The value rises from 140.28 thousand male deaths in 2024 to 144.76 thousand in 2028. Compared to 2023, where detailed values remain unspecified, this trend suggests an average annual increase in mortality rates. The year-on-year growth is relatively stable, with each subsequent year seeing a rise in deaths by approximately 1 to 1.2 thousand. Over the five-year period, the Compound Annual Growth Rate (CAGR) underscores this consistency.
In future trends, watch for influences such as environmental changes, healthcare advancements, and preventative measures that could either exacerbate or alleviate these mortality rates. Additionally, policy interventions targeting respiratory health could crucially impact the trajectory beyond 2028.
